Phase 1 Stroke Trial, Recruiting NCT05158101 Sponsor: The Foundation for Orthopaedics and Regenerative Medicine Condition: Stroke
Back to Stroke

Phase 1 Stroke Trial, Recruiting

NCT05158101
Recruiting Phase 1

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have been diagnosed with a stroke
  • People who are willing and able to understand and sign a written consent form

Who may not be able to join:

  • People who currently have an active infection
  • People who currently have active cancer
  • People who have chronic failure of multiple major organs
  • People who are pregnant
  • People whose pre-treatment blood or lab tests show significant abnormal results
  • People who have a medical condition that the trial doctor believes could put their safety at risk
  • People who are currently misusing or abusing drugs
  • Women who have not yet gone through menopause and are not using contraception
  • People who have previously had an organ transplant
  • People who have a known allergy or sensitivity to sulfur

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
Phase 1: approximately ~10% of drugs entering this phase reach regulatory approval, based on published industry-wide historical data. This is not specific to this trial.
Phase success rates shown are historical industry-wide averages based on published data. They are not a prediction for this specific trial or your individual situation.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Phase 1
Sponsor
The Foundation for Orthopaedics and Regenerative Medicine
Registry
ClinicalTrials.gov
Start date
1 February 2022
Est. completion
1 February 2026

Where this trial is recruiting

Antigua and Barbuda 🇦🇷 Argentina

Primary endpoints

Safety (adverse events)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov